Top

Gepubliceerd in:

01-05-2014 | Original Paper

Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools

Auteurs: Joseph B. Ryan, Antonis Katsiyannis, Mickey Losinski, Robert Reid, Cynthia Ellis

Gepubliceerd in: Journal of Child and Family Studies | Uitgave 4/2014

Abstract

It is currently estimated that up to 6 million children take psychotropic medications for the treatment of mental health problems. The highest prevalence rates (50–76 %) are typically found among students with special needs, especially among those with ADHD and emotional disturbance. The Individuals with Disabilities Education Act (IDEA) and Section 504 of the Rehabilitation Act of 1973 require medications be administered by schools whenever it is deemed necessary for the child to have access to educational services. However, these requirements do not extend to all students, nor do they provide guidance regarding the safest and most efficacious manner in which psychotropic medications should be administered. The authors reviewed existing state medication policies and guidelines to assess the level of guidance currently provided to school staff. Results showed the vast majority of states (48) provided guidance related to the administration of medications to students, with slightly fewer (44) states discussing required documentation procedures. Surprisingly, only 15 states addressed monitoring students for adverse side effects of medications, and even fewer (11) states specifically discussed psychotropic medication in their policies/guidelines. The vast majority (42) of states also addressed requirements for the safe and proper storage of medications, while slightly more than half of all states (31) provided any guidance regarding training of unlicensed personnel (e.g., secretaries) who frequently administer medications to students. The authors highlight several model guidelines/policies and review recommendations for best practice.

vorige artikel A Model of Pediatric Psychopharmacology-Psychotherapy Treatment Integration in the Ambulatory Clinical Setting

volgende artikel A Review of Recent FDA Drug Safety Communications for Pediatric Psychotropics

Abikoff, H., Hechtman, L., Klein, R., Weiss, G., Fleiss, K., Etcovitch, J., et al. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of American Academy of Child and Adolescent Psychiatry, 43, 802–811.CrossRef

Adler, L. A., Reingold, L. S., Morrill, M. S., & Wilens, T. E. (2006). Combination pharmacotherapy for adult ADHD. Current Psychiatry Reports, 8, 409–415.PubMedCrossRef

Almasi, E. A., Stafford, R. S., Kravitz, R. L., & Mansfield, P. R. (2006). What are the public health effects of direct-to-consumer drug advertising? PLos Medicine, 3(3), 145–150.CrossRef

American Academy of Child and Adolescent Psychiatry. (2007). Practice parameters for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 894–921.CrossRef

American Academy of Child and Adolescent Psychiatry. (2009). Practice parameters on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 961–973.CrossRef

American Academy of Pediatrics. (2009). Policy statement—guidance for the administration of medication in school. Pediatrics, 124, 1244–1251.CrossRef

Anderson, L., Walcott, C., Reck, S., & Landau, S. (2009). Issues in monitoring medication effects in the classroom. Psychology in the Schools, 46, 820–826.CrossRef

Avena, J., & Kalman, T. (2010). Do psychotherapists speak to psychopharmacologists? A survey of practicing clinicians. Journal of the American Academy of Psychoanalysis & Dynamic Psychiatry, 38(4), 675–683.CrossRef

Bray, J., Clarke, C., Brennen, G., & Muncey, T. (2008). Should we be pushing meds? The implications of pharmacogenomics. Journal of Psychiatric and Mental Health Nursing, 15, 357–364.PubMedCrossRef

Bussing, R., & Gary, F. A. (2001). Practice guidelines and parental ADHD treatment evaluations: Friends or foes? Harvard Review of Psychiatry, 9(5), 223–233.PubMedCrossRef

Cedar Rapids Community School District v. Garrett F., 106 U.S. 822 (1999).

Center for Health and HealthCare in Schools. (2007). Psychotropic drugs and children: A 2007 update. Saint Louis, MO: The School of Public health and Health Services, The George Washington University. Retrieved from http://www.healthinschools.org/~/media/1F79BC0050C64BF9B79EAB1FD0A21D21.ashx.

Cohen, D., McCubbin, M., Collin, J., & Perodeau, G. (2001). Medications as social phenomena. Health, 5(4), 441–469.

Connor, D. F., Boone, R. T., Steingard, R. J., Lopez, I. D., & Melloni, R. H. (2003). Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11, 157–168.CrossRef

Copeland, E. D. (1995). Medications for attention disorders (ADHD/ADD) and related medical problems. Atlanta, GA: SPI Press.

Council for Exceptional Children. (2013). Best practices for administering medication in school. Retrieved from http://oldsite.cec.sped.org/AM/Template.cfm?Section=Family_Involvement&ContentID=11752&template=/CM/ContentDisplay.cfm.

Dulcan, M. K. (2007). Helping parents, youth, and teachers understand medications for behavioral and emotional problems. Washington, DC: American Psychiatric Press, Inc.CrossRef

DuPaul, G. J., & Carlson, J. (2005). Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly, 20, 206–221.CrossRef

DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (1998). The ADHD rating scale-IV: Checklists, norms and clinical interpretation. New York, NY: Guilford Press.

DuPaul, G. J., & Stoner, G. (2003). ADHD in the schools: Assessment and intervention strategies (2nd ed.). New York, NY: Guilford Press.

Ellis, C. R., Lutz, R. E., Schaefer, G. B., & Woods, K. E. (2007). Physician collaboration involving students with autism spectrum disorders. Psychology in the Schools, 44, 737–747.CrossRef

Epstein, J. N., & Langberg, J. M. (2009). Improving ADHD care with community based interventions in primary care. National Alliance on Mental Illness Beginnings, 14, 7–8.

Forness, S. R. (2011). Special education and the new mental health. Behavioral Disorders, 37, 41–46.

Forness, S. R., Kavale, K. A., & Davanzo, P. A. (2002). The new medical model: Interdisciplinary treatment and the limits of behaviorism. Behavioral Disorders, 27(2), 168–178.

Gureasko-Moore, D., DuPaul, G. J., & Power, T. (2005). Stimulant treatment for attention-deficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.

HaileMariam, A., Bradley-Johnson, S., & Johnson, C. (2002). Pediatrician’s preferences for ADHD information from schools. School Psychology Review, 31, 94–105.

Individuals with Disabilities Education Improvement Act of 2004, 20 U.S.C. § 1400 et seq.(2004). (reauthorization of the Individuals with Disabilities Education Act of 1990).

Irving Independent School District v. Tatro, 468 U.S. 883 (1984).

Jackson, D., & Peters, K. (2008). Use of drug therapy in children with attention deficit hyperactivity disorder (ADHD): Maternal views and experiences. Journal of Clinical Nursing, 17, 2725–2732.PubMedCrossRef

Jacobs, R., Becker-Weidman, E., Reinecke, M., Jordan, N., Silva, S., Rohde, P., et al. (2010). Treating depression and oppositional behavior in adolescents. Journal of Clinical Child and Adolescent Psychology, 39, 559–567.PubMedCentralPubMedCrossRef

McIntyre, R. S., & Jerrell, J. M. (2009). Polypharmacy in children and adolescents treated for major depressive disorder: A claims database study. Journal of Clinical Psychiatry, 70(2), 240–246.PubMedCrossRef

Molina, B., Hinshaw, S., Swanson, J., Arnold, L., Vitiello, B., Jensen, P., et al. (2009). MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 484–500.PubMedCentralPubMedCrossRef

Olfson, M., Gameroff, M. J., Marcus, S. C., & Jensen, P. S. (2003). National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry, 160, 1071–1077.PubMedCrossRef

Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 514–521.PubMedCrossRef

Oswald, D. P. (2002). The new medical model and beyond: A response to Forness and Kavale. Behavioral Disorders, 27, 155–157.

Pappadopulos, E., MacIntyre, J. C., Crimson, M. L., Findling, R. L., Malone, R. P., Derivan, A., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 145–161.PubMedCrossRef

Reid, R., & Johnson, J. (2012). Teacher’s guide to ADHD. New York: Guilford Press.

Roberts, H. J., Floress, M. T., & Ellis, C. R. (2009). Training school psychologists in psychopharmacology consultation. Psychology in the Schools, 46, 827–835.CrossRef

Rozalski, M., Katsiyannis, A., Ryan, J., Collins, T., & Stewart, A. (2010). Americans with disabilities act amendments of 2008. Journal of Disability Policy Studies, 21, 22–28.CrossRef

Runnheim, V. A., Frankenberger, W. R., & Hazelkorn, M. N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorders, 21, 306–314.

Ryan, J. B., & Katsiyannis, A. (2009). The importance of teacher involvement in medication therapy. TEACHING Exceptional Children Plus, 6(2) Article 1. Retrieved from http://escholarship.bc.edu/education/tecplus/vol6/iss2/art1.

Ryan, J. B., Katsiyannis, A., & Hughes, E. (2011). Medication treatment for attention deficit hyperactivity disorder. Theory into Practice, 50(1), 1–9.CrossRef

Ryan, J. B., Reid, R., & Ellis, C. (2008a). A survey of special educator knowledge regarding psychotropic interventions for students with emotional and behavioral disorders. Remedial & Special Education, 29(5), 269–279.CrossRef

Ryan, J. B., Reid, R., Gallagher, K., & Ellis, C. (2008b). Prevalence rates of psychotropic medications for students placed in residential care. Behavioral Disorders, 33(2), 99–107.

Section 504 of the Rehabilitation Act of 1973, 34 C.F.R. Part 104, Subpart D-Preschool, Elementary, and Secondary Education. Retrieved from http://www.ed.gov/policy/rights/reg/ocr/edlite-34cfr104.html#E.

Seida, J. C., Schouten, J. R., Boylan, K., Newton, A. S., Mousavi, S. S., Beaith, A., et al. (2012). Antipsychotics for children and young adults: A comparative effectiveness review. Pediatrics, 129(3), 771–784. doi:10.1542/peds.2011-2158.CrossRef

Singh, I. (2004). Doing their jobs: Mothering with Ritalin in a culture of mother-blame. Social Science and Medicine, 59(6), 1193–1205.PubMedCrossRef

Snider, V. E., Busch, T., & Arrowood, L. (2003). ADHD teacher knowledge of stimulant medication and ADHD. Remedial and Special Education, 24(1), 46–56.CrossRef

Stahl, S. M. (2013). Stahl’s essential pscyhopharmacology (4th ed.). San Diego, CA: Cambridge University Press.

Swanson, J. M. (1992). School-based assessments and interventions for ADD students. Irvine, CA: KC Publishing.

US Food and Drug Administration (2004). “Black box” warning For antidepressants. Retrieved from www.fda.gov/bbs/topics/news/2004/new01116.html.

Wilens, T. E., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., Ultzinger, L., et al. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of American Academy of Child & Adolescent Psychiatry, 1, 21–31.CrossRef

Wolraich, M. L., Bard, D. E., Stein, M. T., Rushton, J. L., & O’Connor, K. G. (2010). Pediatricians’ attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines. Journal of Attention Disorders, 13, 563–572.PubMedCrossRef

Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2, p. 24. Advance online publication. doi:10.1186/1753-2000-2-24 PMCID: PMC2566553.

Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–1030.PubMedCrossRef

Titel: Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools
Auteurs: Joseph B. Ryan
Antonis Katsiyannis
Mickey Losinski
Robert Reid
Cynthia Ellis
Publicatiedatum: 01-05-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Child and Family Studies / Uitgave 4/2014
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843
DOI: https://doi.org/10.1007/s10826-013-9805-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2014

Use of Psychotropic Medications Among Youth in Treatment Foster Care

Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children

Use of Psychiatric Medications in Juvenile Detention Facilities and the Impact of State Placement Policy

The Subjective Experience of Being Medicated in Troubled Youth: A Sample from Residential Treatment

A Review of Recent FDA Drug Safety Communications for Pediatric Psychotropics

Outpatient Psychotropic Medication Use in the US: A Comparison Based on Foster Care Status